Search

Allowing academics to move their pensions from country-to-country when taking up jobs at institutions across the EU has broad support. But there is a swathe of technical and legal detail to sort out and universities need to sign up

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.

Imperial has the greatest concentration of high impact research of any major UK university, according to the Research Excellence Framework (REF) 2014.

A total of 22 new companies were founded in 2014 by researchers from ETH Zurich. These spin-offs are among the most successful in Switzerland. One of the year's highlights was Covagen, which was acquired for over CHF 200 million. The latest figures also reveal that the university is on the right track with its promotion programmes.

To stay competitive in the global race to develop advanced manufacturing technologies, German industry must define and develop the digital framework for the “Internet of Things,” enabling everything from driverless cars to smart cities and e-health, a top official tells Science|Business

Incessant talk of a North-South R&D divide is not baseless but it’s becoming tired. It is time to try and change things says Carlos Zorrinho, Brussels’ quiet revolutionary

Three out of four Starting grants go to young researchers hosted by Germany, UK, France, the Netherlands, Israel and Spain. There are no grants going to Switzerland

China and the US set the pace on patent filings in 2013, while the number of patent applications received by the European Patent Office fell

ETH Zurich and the University of Zurich are founding a new translational research centre at the interface of medicine, science and engineering: the Wyss Translational Center Zurich. A USD 120 million donation from Dr. h.c. mult. Hansjörg Wyss to the two Zurich universities is making this possible. Through an interdisciplinary approach, the new centre aims to accelerate the development and application of innovative medical therapies and groundbreaking robotic systems.

For five years, robotics expert and Executive Board member Roland Siegwart has held the post of Vice President Research and Corporate Relations. He is now in the process of handing over this vice presidency to his successor, Detlef Günther, but he will always remain a firm fan of ETH Zurich.

A leading HIV expert at Imperial College London, Professor Weber has taken up his appointment as Director of the AHSC.

Innovation clusters in life sciences and raw materials set to start in 2015, following year-long bidding competition

Member states line up 2,000 project proposals in transport, energy and research, for funding from the EU’s new investment scheme

The project aims to bring together researchers, engineers, people from industry and young students and to encourage them to come up with new ideas that are useful for society, says Markus Nordberg of CERN

Europe’s carbon market is not dead in the water, but rather a work in progress, says Andreas Loeschel, who advises Chancellor Angela Merkel on overhauling Germany’s energy mix

An expert panel urges the new European Commission to reap the economic benefits of science on-line

In 2013, the growth rate of private R&D investment in Europe fell to 2.9 per cent, due to falling corporate profits and a weak pharma and tech sector

Interest in the beautiful game did not flow naturally for Pablo Rodriguez, Telefónica’s Director of Research and Innovation. Until he realised how it all looked a lot like computers

Three University of Cambridge projects have been selected as winners in GSK’s 2014 Discovery Fast Track Challenge, which is designed to accelerate the translation of academic research into novel therapies.

A research partnership focused on Automotive Cyber Security Research has been set up by global information assurance specialist NCC Group and WMG, at the University of Warwick.